NZ211247A - Controlled release formulation containing bromocriptine - Google Patents

Controlled release formulation containing bromocriptine

Info

Publication number
NZ211247A
NZ211247A NZ211247A NZ21124785A NZ211247A NZ 211247 A NZ211247 A NZ 211247A NZ 211247 A NZ211247 A NZ 211247A NZ 21124785 A NZ21124785 A NZ 21124785A NZ 211247 A NZ211247 A NZ 211247A
Authority
NZ
New Zealand
Prior art keywords
controlled release
release formulation
formulation containing
containing bromocriptine
bromocriptine
Prior art date
Application number
NZ211247A
Other languages
English (en)
Inventor
O Zuger
N Mazer
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ211247A publication Critical patent/NZ211247A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ211247A 1984-02-29 1985-02-27 Controlled release formulation containing bromocriptine NZ211247A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
NZ211247A true NZ211247A (en) 1989-02-24

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211247A NZ211247A (en) 1984-02-29 1985-02-27 Controlled release formulation containing bromocriptine

Country Status (26)

Country Link
JP (1) JPS60202812A (ru)
AT (1) AT387716B (ru)
AU (2) AU586621B2 (ru)
BE (1) BE901810A (ru)
CA (1) CA1256374A (ru)
CH (2) CH666406A5 (ru)
DE (1) DE3505743C2 (ru)
DK (1) DK175016B1 (ru)
ES (1) ES8705223A1 (ru)
FR (1) FR2560047B1 (ru)
GB (1) GB8405227D0 (ru)
GR (1) GR850506B (ru)
HK (1) HK85490A (ru)
HU (1) HU196121B (ru)
IE (1) IE58235B1 (ru)
IL (1) IL74459A (ru)
IT (1) IT1199948B (ru)
LU (1) LU85791A1 (ru)
MX (1) MX9203626A (ru)
NL (1) NL194231C (ru)
NZ (1) NZ211247A (ru)
PH (1) PH23266A (ru)
PT (1) PT80015B (ru)
SE (2) SE462259B (ru)
SG (1) SG69390G (ru)
ZA (1) ZA851546B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (ru) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
LU85791A1 (fr) 1985-12-11
CH667009A5 (de) 1988-09-15
HUT38254A (en) 1986-05-28
CH666406A5 (de) 1988-07-29
FR2560047A1 (fr) 1985-08-30
IT8547703A0 (it) 1985-02-20
JPS60202812A (ja) 1985-10-14
IL74459A0 (en) 1985-05-31
AU618599B2 (en) 1992-01-02
HU196121B (en) 1988-10-28
CA1256374A (en) 1989-06-27
AT387716B (de) 1989-03-10
DK86785D0 (da) 1985-02-26
PT80015B (pt) 1987-09-18
FR2560047B1 (fr) 1988-01-15
IL74459A (en) 1988-12-30
NL8500417A (nl) 1985-09-16
ZA851546B (en) 1986-10-29
AU3913685A (en) 1985-09-05
BE901810A (fr) 1985-08-26
DE3505743A1 (de) 1985-08-29
ES540807A0 (es) 1987-05-01
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
IE850495L (en) 1985-08-29
IE58235B1 (en) 1993-08-11
JPH0448776B2 (ru) 1992-08-07
ATA58085A (de) 1988-08-15
MX9203626A (es) 1992-09-01
AU3500689A (en) 1989-09-14
ES8705223A1 (es) 1987-05-01
SE8500961D0 (sv) 1985-02-27
PH23266A (en) 1989-06-23
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
DK86785A (da) 1985-08-30
HK85490A (en) 1990-10-25
IT1199948B (it) 1989-01-05
DK175016B1 (da) 2004-04-26
SG69390G (en) 1990-10-26
SE462259B (sv) 1990-05-28
GB8405227D0 (en) 1984-04-04
SE8500961L (sv) 1985-08-30
DE3505743C2 (de) 1995-02-16
GR850506B (ru) 1985-06-28
NL194231B (nl) 2001-06-01

Similar Documents

Publication Publication Date Title
DE3565776D1 (en) Release devices
GB8526591D0 (en) Controlled release powder & process
GB2207353B (en) Controlled release formulation
GB2122490B (en) Controlled release formulation
GB8716323D0 (en) Bromocriptine
NZ214534A (en) Sustained release formulation containing theophylline
GB8525947D0 (en) Occular formulation comprising bromocriptine
CY1564A (en) Bromocriptine compositions
GB8530331D0 (en) Release means
GB2158159B (en) Applicator for crease-setting composition
GB8514030D0 (en) Controlled release iodine
ZA887320B (en) Can carrier composition
NZ211247A (en) Controlled release formulation containing bromocriptine
GB8405085D0 (en) Controlled release formulation
GB8411355D0 (en) Controlled time release therapeutic composition
ZA853797B (en) Release devices
GB8521221D0 (en) Controlled release formulations
GB2199774B (en) Application for crease-setting composition
GB2151137B (en) Slow release formulations
EP0321786A3 (en) Composition for external application
IE840461L (en) Controlled release formulation comprising a¹triazolobenzothiazole
EG17797A (en) Controlled release formulation
IE863030L (en) Controlled release composition
GB8421151D0 (en) Release coating
GB8420729D0 (en) Release coating